Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. The new face of ortho: Zimmer to take 2nd place with $13.4B Biomet buy
The $45 billion musculoskeletal market is getting ever more consolidated and the latest mega-deal will alter the landscape dramatically. With Zimmer’s impending $13.35 billion merger with hometown rival Biomet, we’ll be able to count orthopedics industry giants on one hand.
Prior to the deal, Zimmer sat at 3rd place a respectable 10.3% market share and Biomet took 5th place with about 7% of the market. When they join forces, pending regulatory approvals, the duo will form the 2nd largest player in the industry. Read more
2. Allergan can do better than Valeant offer, investor says
MASSDEVICE ON CALL — Major Allergan shareholder Polen Capital Management isn’t getting worked up about Valeant Pharmaceuticals’ unsolicited $47 billion buyout offer, an executive told reporters.
Despite a cash-and-stock offer that represents a 7% premium, Allergan can do better on its own, Polen chief investment officer Dan Davidowitz told the Wall Street Journal. Read more
1. Boston Children’s Hospital faces cyber threats – Are the medical devices safe?
The hacker group Anonymous calls for internet activists to bombard Boston Children’s Hospital with a flood of internet traffic to disrupt its online services, the same type of attack that has been known to knock out medical devices.
Officials at Boston Children’s Hospital confirmed this week that they’d weathered some digital mayhem affecting the clinic’s web services in the weeks following threats from the online hacker group Anonymous. Read more
